首页> 美国卫生研究院文献>MedChemComm >Towards the rational design of novel drugs based on solubility partitioning/distribution biomimetic permeability and biological activity exemplified by 124-thiadiazole derivatives
【2h】

Towards the rational design of novel drugs based on solubility partitioning/distribution biomimetic permeability and biological activity exemplified by 124-thiadiazole derivatives

机译:基于124-噻二唑衍生物为代表的基于溶解度分配/分布仿生通透性和生物活性的新型药物的合理设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel 1,2,4-thiadiazole derivatives as potent neuroprotectors were synthesized and identified. Their ability to inhibit the glutamate stimulated Ca2+ uptake was investigated. The solubility of thiadiazoles was measured in a buffer solution (pH 7.4) at 298 K. The distribution coefficients in 1-octanol/buffer (pH 7.4) and 1-hexane/buffer (pH 7.4) immiscible phases as model systems imitating the gastrointestinal tract epithelium and the blood–brain barrier were determined. Permeation experiments the new Permeapad™ barrier using Franz diffusion cells were conducted and the apparent permeability coefficients were obtained. The influence of the compound structure on the physicochemical properties determining the bioavailability of drug-like substances was revealed. Solubility–permeability interplay has been assessed to evaluate potential bioavailability of the compounds studied.
机译:合成和鉴定了新型的1,2,4-噻二唑衍生物作为有效的神经保护剂。研究了它们抑制谷氨酸刺激的Ca 2 + 吸收的能力。噻二唑的溶解度在298 K的缓冲溶液(pH 7.4)中进行测量。作为模拟胃肠道的模型系统,在1-辛醇/缓冲液(pH 7.4)和1-己烷/缓冲液(pH 7.4)不混溶相中的分布系数确定上皮和血脑屏障。进行了使用Franz扩散池的新型Permeapad™屏障的渗透实验,并获得了表观渗透系数。揭示了化合物结构对决定类药物物质生物利用度的理化性质的影响。已经评估了溶解度-渗透性相互作用,以评估所研究化合物的潜在生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号